Commodore Capital LP Diversified Active

Location: New York, NY

CIK: 0001831942 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value: $379M (100.0% shares, 0.0% debt)

Holdings (29)

IVERIC BIO INC 11.8%
Value $44.66M Shares 2,750,137 Est. Cost $10.18 Unrealized
ACRS ACLARIS THERAPEUTICS INC 10.4%
Value $39.42M Shares 2,190,291 Est. Cost $12.44 Unrealized +28.8%
CYTK CYTOKINETICS INC 7.5%
Value $28.47M Shares 796,578 Est. Cost $24.17 Unrealized +21.8%
DICERNA PHARMACEUTICALS INC 6.9%
Value $26.05M Shares 1,292,251 Est. Cost $20.16 Unrealized
CCCC C4 THERAPEUTICS INC 5.7%
Value $21.5M Shares 481,094 Est. Cost $29.00 Unrealized +47.7%
KURA KURA ONCOLOGY INC 4.9%
Value $18.72M Shares 999,433 Est. Cost $26.59 Unrealized -29.1%
CELC CELCUITY INC 4.4%
Value $16.57M Shares 920,464 Est. Cost $25.49 Unrealized -16.8%
COGT COGENT BIOSCIENCES INC 4.2%
Value $16.08M Shares 1,912,511 Est. Cost $9.55 Unrealized -19.7%
MERUS N V 4.2%
Value $15.8M Shares 718,136 Est. Cost $22.00 Unrealized
CYMABAY THERAPEUTICS INC 4.0%
Value $15.22M Shares 4,169,896 Est. Cost $4.81 Unrealized
SATSUMA PHARMACEUTICALS INC 3.8%
Value $14.53M Shares 3,118,761 Est. Cost $6.15 Unrealized
VISTAGEN THERAPEUTICS INC 3.7%
Value $14.04M Shares 5,123,509 Est. Cost $2.24 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 3.5%
Value $13.4M Shares 248,207 Est. Cost $18.18 Unrealized +158.1%
VRDN VIRIDIAN THERAPEUTICS INC 2.9%
Value $10.98M Shares 667,674 Est. Cost $15.80 Unrealized -7.2%
TNYA TENAYA THERAPEUTICS INC 2.8%
Value $10.61M Shares 513,930 Est. Cost $21.49 Unrealized 0.0%
IOVA IOVANCE BIOTHERAPEUTICS INC 2.4%
Value $8.948M Shares 362,869 Est. Cost $23.56 Unrealized 0.0%
XENE XENON PHARMACEUTICALS INC 2.3%
Value $8.854M Shares 579,432 Est. Cost $14.47 Unrealized +20.1%
PTGX PROTAGONIST THERAPEUTICS INC 2.3%
Value $8.826M Shares 498,079 Est. Cost $33.71 Unrealized +26.5%
KRONOS BIO INC 1.7%
Value $6.264M Shares 298,839 Est. Cost $29.87 Unrealized
RVMD REVOLUTION MEDICINES INC 1.6%
Value $6.224M Shares 226,228 Est. Cost $29.11 Unrealized 0.0%
GNCAQ GENOCEA BIOSCIENCES INC 1.6%
Value $5.913M Shares 3,079,756 Est. Cost $2.51 Unrealized -21.7%
KALV KALVISTA PHARMACEUTICALS INC 1.4%
Value $5.454M Shares 312,553 Est. Cost $24.62 Unrealized -17.7%
DYN DYNE THERAPEUTICS INC 1.3%
Value $4.955M Shares 305,125 Est. Cost $19.35 Unrealized -8.4%
MREO MEREO BIOPHARMA GROUP PLC 1.3%
Value $4.775M Shares 1,972,958 Est. Cost $3.56 Unrealized
PMVP PMV PHARMACEUTICALS INC 1.0%
Value $3.725M Shares 125,000 Est. Cost $39.23 Unrealized -18.6%
IVA INVENTIVA SA 1.0%
Value $3.719M Shares 262,658 Est. Cost $14.53 Unrealized
BCLS ACQUISITION CORP 0.7%
Value $2.49M Shares 250,000 Est. Cost $11.14 Unrealized
ASTRIA THERAPEUTICS INC 0.6%
Value $2.115M Shares 239,270 Est. Cost $8.84 Unrealized
SPRY SILVERBACK THERAPEUTICS INC 0.3%
Value $969K Shares 97,143 Est. Cost $33.40 Unrealized -26.2%